575 related articles for article (PubMed ID: 20734065)
1. Invariant natural killer T cells: bridging innate and adaptive immunity.
Van Kaer L; Parekh VV; Wu L
Cell Tissue Res; 2011 Jan; 343(1):43-55. PubMed ID: 20734065
[TBL] [Abstract][Full Text] [Related]
2. Invariant natural killer T cells: innate-like T cells with potent immunomodulatory activities.
Wu L; Gabriel CL; Parekh VV; Van Kaer L
Tissue Antigens; 2009 Jun; 73(6):535-45. PubMed ID: 19392798
[TBL] [Abstract][Full Text] [Related]
3. Functions of CD1d-Restricted Invariant Natural Killer T Cells in Antimicrobial Immunity and Potential Applications for Infection Control.
Kinjo Y; Takatsuka S; Kitano N; Kawakubo S; Abe M; Ueno K; Miyazaki Y
Front Immunol; 2018; 9():1266. PubMed ID: 29928278
[TBL] [Abstract][Full Text] [Related]
4. iNKT-cell help to B cells: a cooperative job between innate and adaptive immune responses.
Dellabona P; Abrignani S; Casorati G
Eur J Immunol; 2014 Aug; 44(8):2230-7. PubMed ID: 24782127
[TBL] [Abstract][Full Text] [Related]
5. Strategy of lipid recognition by invariant natural killer T cells: 'one for all and all for one'.
Mallevaey T; Selvanantham T
Immunology; 2012 Jul; 136(3):273-82. PubMed ID: 22671023
[TBL] [Abstract][Full Text] [Related]
6. Positive & Negative Roles of Innate Effector Cells in Controlling Cancer Progression.
Stolk D; van der Vliet HJ; de Gruijl TD; van Kooyk Y; Exley MA
Front Immunol; 2018; 9():1990. PubMed ID: 30298063
[TBL] [Abstract][Full Text] [Related]
7. Invariant natural killer T cells: an innate activation scheme linked to diverse effector functions.
Brennan PJ; Brigl M; Brenner MB
Nat Rev Immunol; 2013 Feb; 13(2):101-17. PubMed ID: 23334244
[TBL] [Abstract][Full Text] [Related]
8. The ins and outs of type I iNKT cell development.
Shissler SC; Webb TJ
Mol Immunol; 2019 Jan; 105():116-130. PubMed ID: 30502719
[TBL] [Abstract][Full Text] [Related]
9. Innate and adaptive stimulation of murine diverse NKT cells result in distinct cellular responses.
Tripathi P; Sedimbi SK; Singh AK; Löfbom L; Issazadeh-Navikas S; Weiss S; Förster I; Karlsson MCI; Yrlid U; Kadri N; Cardell SL
Eur J Immunol; 2019 Mar; 49(3):443-453. PubMed ID: 30427069
[TBL] [Abstract][Full Text] [Related]
10. Invariant natural killer T cell-based immunotherapy for cancer.
Motohashi S; Nakayama T
Immunotherapy; 2009 Jan; 1(1):73-82. PubMed ID: 20635975
[TBL] [Abstract][Full Text] [Related]
11. Hiding lipid presentation: viral interference with CD1d-restricted invariant natural killer T (iNKT) cell activation.
Horst D; Geerdink RJ; Gram AM; Stoppelenburg AJ; Ressing ME
Viruses; 2012 Oct; 4(10):2379-99. PubMed ID: 23202469
[TBL] [Abstract][Full Text] [Related]
12. Activation and Function of iNKT and MAIT Cells.
Chandra S; Kronenberg M
Adv Immunol; 2015; 127():145-201. PubMed ID: 26073984
[TBL] [Abstract][Full Text] [Related]
13. Invariant natural killer T cells balance B cell immunity.
Leadbetter EA; Karlsson MCI
Immunol Rev; 2021 Jan; 299(1):93-107. PubMed ID: 33438287
[TBL] [Abstract][Full Text] [Related]
14. Activation strategies for invariant natural killer T cells.
Kohlgruber AC; Donado CA; LaMarche NM; Brenner MB; Brennan PJ
Immunogenetics; 2016 Aug; 68(8):649-63. PubMed ID: 27457886
[TBL] [Abstract][Full Text] [Related]
15. How invariant natural killer T cells respond to infection by recognizing microbial or endogenous lipid antigens.
Brigl M; Brenner MB
Semin Immunol; 2010 Apr; 22(2):79-86. PubMed ID: 19948416
[TBL] [Abstract][Full Text] [Related]
16. Invariant natural killer T cells as sensors and managers of inflammation.
Van Kaer L; Parekh VV; Wu L
Trends Immunol; 2013 Feb; 34(2):50-8. PubMed ID: 23017731
[TBL] [Abstract][Full Text] [Related]
17. Glycolipid ligands of invariant natural killer T cells as vaccine adjuvants.
Kim S; Lalani S; Parekh VV; Wu L; Van Kaer L
Expert Rev Vaccines; 2008 Dec; 7(10):1519-32. PubMed ID: 19053208
[TBL] [Abstract][Full Text] [Related]
18. iNKT cells in microbial immunity: recognition of microbial glycolipids.
Kinjo Y; Ueno K
Microbiol Immunol; 2011 Jul; 55(7):472-82. PubMed ID: 21434991
[TBL] [Abstract][Full Text] [Related]
19. Activated invariant natural killer T cells directly recognize leukemia cells in a CD1d-independent manner.
Aoki T; Takami M; Takatani T; Motoyoshi K; Ishii A; Hara A; Toyoda T; Okada R; Hino M; Koyama-Nasu R; Kiuchi M; Hirahara K; Kimura MY; Nakayama T; Shimojo N; Motohashi S
Cancer Sci; 2020 Jul; 111(7):2223-2233. PubMed ID: 32324315
[TBL] [Abstract][Full Text] [Related]
20. Invariant natural killer T cells: front line fighters in the war against pathogenic microbes.
Crosby CM; Kronenberg M
Immunogenetics; 2016 Aug; 68(8):639-48. PubMed ID: 27368411
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
